Policy letters and testimony

The PAN Foundation and the National Council on Aging, with the support of 68 leading national organizations, urged the Centers for Medicare & Medicaid Services (CMS) to further enhance the Low-Income Subsidy program. While these organizations recognized the progress made in expanding eligibility requirements through the Inflation Reduction Act, this letter outlines non-legislative action steps that CMS can take to increase enrollment in the program and help more people with low-income access their prescription medications.

The PAN Foundation joined 71 organizations representing millions of patients in providing comments in response to the 2024 Notice of Benefit and Payment Parameters (NBPP) proposed rule. The letter urges the U.S. Department of Health and Human Services (HHS) to lower copay amounts for specialty drugs, prohibit co-pay accumulators, maximizers, and similar programs, and address insurers and pharmacy benefit managers that discriminate against beneficiaries with chronic health conditions.

The PAN Foundation provided comments in response to the 2024 Notice of Benefit and Payment Parameters (NBPP) proposed rule, urging the U.S. Department of Health and Human Services (HHS) to prohibit co-pay accumulators, maximizers, and similar programs and address harmful efforts to circumvent requirements related to patient cost sharing limits.

The PAN Foundation joined the All Copays Count Coalition to provide comments in response to the proposed rule on Section 1557 of the ACA, urging Health and Human Services to address discriminatory practices that target patients with disabilities.